Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation
Michelle E. Farrell(Harvard University), Rachel F. Buckley(Harvard University), Aaron P. Schultz(Harvard University), J. Alex Becker(Jacobson Holman (United States)), Rebecca A. Betensky(Harvard University), Bernard Hanseeuw(Cliniques Universitaires Saint-Luc), Shu Jiang(Washington University in St. Louis), Heidi I.L. Jacobs(Harvard University), Kathryn V. Papp(Brigham and Women's Hospital), Julie C. Price(Harvard University), Dorene M. Rentz(Brigham and Women's Hospital), Elizabeth C. Mormino(Allen Institute for Brain Science), Michael J Properzi(Massachusetts General Hospital), Keith A. Johnson(Brigham and Women's Hospital), Victor L. Villemagne(The University of Melbourne), Reisa A. Sperling(Harvard University)
Cited by 124
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k